Alimera sciences, inc. announces regulatory approval for iluvien® in benelux countries for the treatment of non-infectious posterior uveitis
Alimera sciences, inc. announced that the governmental agencies that oversee the availability of medical products in belgium, the netherlands and luxembourg, collectively known as the benelux countries, have each granted marketing authorization for iluvien® for prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. the complete benelux approval was achieved when the netherlands’ medicines evaluation board informed alimera of their approval on november 6, 2019. the approval by belgium’s federal agency for medicines and health products was received in may of 2019, and luxembourg’s heads of medicines agencies provided its confirmation of regulatory approval in late october. alimera announced in september that it was expanding its relationship with french distribution partner, horus pharmaceuticals, who will help the company achieve reimbursement in all three countries, after which it will oversee distribution throughout benelux for the new indication.
ALIM Ratings Summary
ALIM Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission